Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs low-dose quetiapine vs placebo in adolescents with psychiatric disorders and insomnia
2024-519597-39-00Phase 3Authorised
- Sponsor
- Psykiatrisk Center København
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Insomnia and mental disorder comparing Melatonin, Low-dose quetiapine and Placebo (3 arms). Primary endpoint: Insomnia severity using the Insomnia Severity Index (ISI). Planned start Apr 2025; status: authorised.
02
Drugs
melatoninquetiapine
03
Conditions
Insomniamental disorder
Beyond the preview
Go deeper on 2024-519597-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519597-39-00.